{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:59:55Z","timestamp":1725605995745},"publisher-location":"Basel","reference-count":33,"publisher":"Birkh\u00e4user Basel","isbn-type":[{"type":"print","value":"9783034899314"},{"type":"electronic","value":"9783034891608"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/978-3-0348-9160-8_21","type":"book-chapter","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T11:09:35Z","timestamp":1315566575000},"page":"226-235","source":"Crossref","is-referenced-by-count":0,"title":["Variability of Methotrexate Pharmacokinetics and Pharmacodynamics"],"prefix":"10.1007","author":[{"given":"A. H.","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Grygiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1749-6632.1971.tb46996.x","volume":"186","author":"ID Goldman","year":"1971","unstructured":"Goldman ID. The characteristics of membrane transport of amethopterin and the naturally occuring folates. Ann. N.Y. Academ. Sci. 186: 400\u2013422, (1971).","journal-title":"Ann. N.Y. Academ. Sci."},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1056\/NEJM198301273080406","volume":"308","author":"GA Curt","year":"1983","unstructured":"Curt GA, Carney DSf Cowan KH, Jolivet J, Bailey BD, Drake JC, Kao-Shan CS, Minna JD and Chabner BA. Unstable methotrexate resistance in human small-cell carcinoma associated with double-minute chromosomes. N. Engl. J. Med. 308: 199\u2013202, (1983).","journal-title":"N. Engl. J. Med."},{"key":"21_CR3","first-page":"1018","volume":"25","author":"ES Henderson","year":"1965","unstructured":"Henderson ES, Adamson RH and Oliverio VT. The metabolic fate of tritiated methotrexate II. Absorption and excretion in man. Cancer Res. 25: 1018\u20131024, (1965).","journal-title":"Cancer Res."},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/1097-0142(197511)36:5<1619::AID-CNCR2820360514>3.0.CO;2-G","volume":"36","author":"M Freeman-Narrod","year":"1975","unstructured":"Freeman-Narrod M, Gerstly BJ, Engstrom PF and Bornstein RS. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer 36: 1619\u20131624 (1975).","journal-title":"Cancer"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-197803010-00001","volume":"3","author":"DD Shen","year":"1978","unstructured":"Shen DD and Azarnoff DL. Clinical pharmacokinetics of methotrexate. Clin. Pharmacokinet. 3: 1\u201313 (1978).","journal-title":"Clin. Pharmacokinet"},{"key":"21_CR6","first-page":"188","volume":"11","author":"BM Colls","year":"1983","unstructured":"Colls BM, Robson RA, Robinson BA and Tisch GW. Serum profiles and safety of intermediate-dose (500\u20131000mg) methotrexate following IV and IM administration. Cancer Chemother. Pharmacol. 11: 188\u2013190 (1983).","journal-title":"Pharmacol."},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/clpt.1984.47","volume":"35","author":"J Edelman","year":"1984","unstructured":"Edelman J, Biggs DF, Jamali F and Russell AS. Low-dose methotrexate kinetics in arthritis. Clin. Pharmacol. Ther. 35: 382\u2013386, (1984).","journal-title":"Clin. Pharmacol. Ther."},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cpt1973144part1572","volume":"14","author":"DH Huffman","year":"1973","unstructured":"Huffman DH, Wan SH, Azarnoff DL and Hoogstraten B. Pharmacokinetics of methotrexate. Clin. Pharmacol. Ther. 14: 572\u2013579 (1973).","journal-title":"Clin. Pharmacol. Ther."},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1126\/science.166.3907.887","volume":"166","author":"DS Zaharko","year":"1969","unstructured":"Zaharko DS, Bruckner H and Oliverio VT. Antiobiotics alter methotrexate metabolism and excretion. Science 166: 887\u2013888 (1969).","journal-title":"Science"},{"key":"21_CR10","first-page":"3487","volume":"34","author":"SH Wan","year":"1974","unstructured":"Wan SH, Huffman DH, Azarnoff DL, Stephens R and Hoogstraten B. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res. 34: 3487\u20133491, (1974).","journal-title":"Cancer Res."},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cpt197926163","volume":"26","author":"RC Donehower","year":"1979","unstructured":"Donehower RC, Hande KR, Drake JC and Chabner BA. Presence of 2, 4-diamino-N10-methylpteroic acid after high dose methotrexate. Clin. Pharmacol. Ther. 26: 63\u201372, (1979).","journal-title":"Clin. Pharmacol. Ther."},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1172\/JCI108308","volume":"57","author":"SA Jacobs","year":"1976","unstructured":"Jacobs SA, Stoller RG, Chabner BA and Johns DG. 7-hydroxy-methotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high-dose methotrexate. J. Clin. Invest. 57: 534\u2013538 (1976).","journal-title":"J. Clin. Invest."},{"key":"21_CR13","first-page":"2985","volume":"35","author":"VM Whitehead","year":"1975","unstructured":"Whitehead VM, Perrault MM and Stelener S. Tissue synthesis of methotrexate polyglutamates in the rat. Cancer Res. 35: 2985\u20132990 (1975).","journal-title":"Cancer Res."},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/art.1780290703","volume":"29","author":"JM Kremer","year":"1986","unstructured":"Kremer JM, Galivan J, Streckfuss A and Kamen B. Methotrexate metabolism analysis inblood and liver of rheumatoid arthritis patients. Arthritis Rheum. 29: 832\u2013835, (1986).","journal-title":"Arthritis Rheum."},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/cpt1969106849","volume":"10","author":"DG Liegler","year":"1969","unstructured":"Liegler DG, Henderson ES, Hahn MA and Oliverio VT: The effects of organic acids on renal clearance of methotrexate in man. Clin. Pharmacol Ther. 10: 849\u2013857, (1969)","journal-title":"Pharmacol Ther."},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0002-9343(83)90477-1","volume":"75","author":"RT Hoffmeister","year":"1983","unstructured":"Hoffmeister RT. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am. J. Med. 75: 69\u201373, (1983).","journal-title":"Am. J. Med."},{"key":"21_CR17","first-page":"501","volume":"7","author":"RF Wilkens","year":"1980","unstructured":"Wilkens, RF, Watson MA, Paxson CS. Low dose pulse methotrexate therapy in rheumatoid arthritis. J. Rheumat. 7: 501\u2013505, (1980).","journal-title":"J. Rheumat."},{"key":"21_CR18","first-page":"860","volume":"9","author":"K Steinsson","year":"1982","unstructured":"Steinsson K, Weinstein A, Korn J and Abeles M. Low dose methotrexate in rheumatoid arthritis. J. Rheumat. 9: 860\u2013866, (1982).","journal-title":"J. Rheumat."},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/art.1780250312","volume":"25","author":"RM Michaels","year":"1982","unstructured":"Michaels, RM, Nashel DJ, Leonard A, Sliwinski AJ and Derbes SJ. Weekly intravenous methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum. 25: 339\u2013341, (1982).","journal-title":"Arthritis Rheum."},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0002-9343(85)90312-2","volume":"79","author":"A Weinstein","year":"1985","unstructured":"Weinstein A, Marlowe S, Korn J and Farouhar F. Low-dose methotrexate of rheumatoid arthritis: long-term observations. Am. J. Med. 79: 331\u2013337, (1985).","journal-title":"Am. J. Med."},{"issue":"138","key":"21_CR21","first-page":"S36","volume":"28","author":"CS Alarcon","year":"1985","unstructured":"Alarcon CS, Guyton JM, Acion RT, Barger BO and Koopman WJ. Toxicity to methotrexate in rheumatoid arthritis: clinical and HLA studies. Arthritis Rheum. 28 (Suppl. 138): S36, (1985).","journal-title":"Arthritis Rheum."},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.1780290702","volume":"29","author":"JM Kremer","year":"1986","unstructured":"Kremer JM and Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum. 29: 822\u2013831, (1986).","journal-title":"Arthritis Rheum."},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/rheumatology\/25.4.372","volume":"25","author":"PN Sambrook","year":"1986","unstructured":"Sambrook PN, Champion GD, Browne CD, Cohen ML, Compton P, Day RO and De Jager J: Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: a life-table analysis. Br. J. Rheum. 25: 372\u2013375, (1986).","journal-title":"Br. J. Rheum."},{"key":"21_CR24","unstructured":"Erikson N and Furst DE. Significant methotrexate toxicity in RA patients: results of an ongoing long-term prospective trial. Arthritis Rheum.30 (Suppl. S59) (1987)."},{"issue":"D57","key":"21_CR25","first-page":"S61","volume":"28","author":"AG DiBartolomeo","year":"1984","unstructured":"DiBartolomeo AG, Mayes MD and Barthon JM. Methotrexate in rheumatoid arthritis: a longitudinal study of liver biopsies. Arthritis Rheum. 28 (Suppl. D57) S61, (1984).","journal-title":"Arthritis Rheum."},{"issue":"141","key":"21_CR26","first-page":"S37","volume":"28","author":"J Aponte","year":"1985","unstructured":"Aponte J and Petrelli M. Hepatic histology following prolonged treatment of rheumatoid arthritis with bolus methotrexate. Arthritis Rheum. 28 (Suppl. 141) S37, (1985).","journal-title":"Arthritis Rheum."},{"key":"21_CR27","unstructured":"Koo AP, Mackenzie AH, Tuthill RJ and Leatherman JR. Liver histology in rheumatoid arthritis before and after prolonged methotrexate therapy. Arthritis Rheum. 28 (Suppl. 14) (1985)."},{"issue":"D12","key":"21_CR28","first-page":"S77","volume":"28","author":"FF Wilkens","year":"1985","unstructured":"Wilkens FF, Clegg DO, Ward JR, Marks CR, Greene ML, Tolman KG, Roth GJ, Jackson CG and Leonard PA. Liver biopsies in patients on low dose pulse methotrexate for the treatment of rheumatoid arthritis. Arthritis Rheum. 28 (Suppl. D12): S77, (1985).","journal-title":"Arthritis Rheum."},{"issue":"C32","key":"21_CR29","first-page":"S76","volume":"29","author":"R Rau","year":"1986","unstructured":"Rau R and Karger T. Liver biopsy findings in patients in rheumatoid arthritis and psoriatic arthritis on long term treatment with methotrexate. Arthritis Rheum. 29 (Suppl. C32) S76, (1986).","journal-title":"Arthritis Rheum."},{"key":"21_CR30","first-page":"129","volume":"52","author":"AH Mackenzie","year":"1985","unstructured":"Mackenzie AH. Hepatoxicity of prolonged methotrexate therapy for rheumatoid arthritis. Cleveland Clin. Quarterly 52: 129\u2013135, (1985).","journal-title":"Quarterly"},{"key":"21_CR31","unstructured":"Segal AM, Koo A, Calaboese L, Mazanec D, Steinbrunner J, Wrabel C, Medendorp SV. Twenty year experience of methotrexate experience in rheumatoid arthritis. Arthritis Rheum. 30 (Suppl. S59) (1987)."},{"issue":"61","key":"21_CR32","first-page":"S26","volume":"27","author":"GW Cannon","year":"1984","unstructured":"Cannon GW, Clegg DO, Samuelson CO and Ward JR. Pulmonary toxicity during treatment of rheumatoid arthritis with methotrexate: prevalence, clinical features, treatment and follow-up. Arthritis Rheum. 27 (suppl. 61) S26, (1984).","journal-title":"Arthritis Rheum."},{"key":"21_CR33","unstructured":"Bell MJ, Geddie WR, Gordon DA and Reynolds WJ. Pre-existing lung disease in patients with rheumatoid arthritis may predispose to methotrexate lung. Arthritis Rheum. 29 (Suppl. S75) (1986)."}],"container-title":["Basis for Variability of Response to Anti-Rheumatic Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-0348-9160-8_21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T16:01:08Z","timestamp":1619971268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-0348-9160-8_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"ISBN":["9783034899314","9783034891608"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-3-0348-9160-8_21","relation":{},"subject":[],"published":{"date-parts":[[1988]]}}}